In a double-blind study with a placebo group, chronic insomniac patients administered with a DSIP analogue experienced a reduction in sleep latency by an average of 22 minutes, suggesting its potential as a therapeutic agent for severe chronic insomnia patients (Anderer & Saletu, 1991)
Over time, this buildup can contribute to neurological disorders, chronic fatigue, weakened immune function, and organ damage
Comparison of isothiocyanate metabolite levels and histone deacetylase activity in human subjects consuming broccoli sprouts or broccoli supplement. Journal of agricultural and food chemistry 59, no
Evidence level: Primary regulatory Sources: July 23-24, 2026 Pharmacy Compounding Advisory Committee meeting, Certain bulk drug substances for use in compounding may present significant safety risks How to read this: An advisory committee proceeding is part of a regulatory process
We next tested PDS5B together with miniBRCA2-DSS1 for possible functional cooperation in presynaptic filament assembly (Fig